Lipotoxicity and steatohepatitis in an overfed mouse model for non-alcoholic fatty liver disease

被引:86
作者
Gaemers, Ingrid C. [1 ]
Stallen, Jan M. [1 ]
Kunne, Cindy [1 ]
Wallner, Christian [2 ]
van Werven, Jochem [2 ]
Nederveen, Aart [2 ]
Lamers, Wouter H. [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 BK Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2011年 / 1812卷 / 04期
关键词
Non-alcoholic fatty liver disease; Steatohepatitis; Liver; Overnutrition; High-fat diet; Endoplasmatic reticulum stress; Adipose tissue; ENDOPLASMIC-RETICULUM STRESS; HEPATIC CYTOCHROME-P450 2E1; UNFOLDED PROTEIN RESPONSE; SERUM FGF21 LEVELS; OXIDATIVE STRESS; INSULIN SENSITIVITY; METABOLIC SYNDROME; DIABETES-MELLITUS; HEME OXYGENASE-1; ADIPOSE-TISSUE;
D O I
10.1016/j.bbadis.2011.01.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
The major risk factors for non-alcoholic fatty liver disease (NAFLD) are obesity, insulin resistance and dyslipidemia. The cause for progression from the steatosis stage to the inflammatory condition (non-alcoholic steatohepatitis (NASH)) remains elusive at present. Aim of this study was to test whether the different stages of NAFLD as well as the associated metabolic abnormalities can be recreated in time in an overfed mouse model and study the mechanisms underlying the transition from steatosis to NASH. Male C57BI/6J mice were subjected to continuous intragastric overfeeding with a high-fat liquid diet (HFLD) for different time periods. Mice fed a solid high-fat diet (HFD) ad libitum served as controls. Liver histology and metabolic characteristics of liver, white adipose tisue (WAT) and plasma were studied. Both HFD-fed and HFLD-overfed mice initially developed liver steatosis, but only the latter progressed in time to NASH. NASH coincided with obesity, hyperinsulinemia, loss of liver glycogen and hepatic endoplasmatic reticulum stress. Peroxisome proliferator-activated receptor gamma (Ppary), fibroblast growth factor 21 (Fgf21), fatty acid binding protein (Fabp) and fatty acid translocase (CD36) were induced exclusively in the livers of the HFLD-overfed mice. Inflammation, reduced adiponectin expression and altered expression of genes that influence adipogenic capacity were only observed in WAT of HFLD-overfed mice. In conclusion: this dietary mouse model displays the different stages and the metabolic settings often found in human NAFLD. Lipotoxicity due to compromised adipose tissue function is likely associated with the progression to NASH, but whether this is cause or consequence remains to be established. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:447 / 458
页数:12
相关论文
共 53 条
[1]
Mouse models in non-alcoholic fatty liver disease and steatohepatitis research [J].
Anstee, QM ;
Goldin, RD .
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2006, 87 (01) :1-16
[2]
A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet [J].
Baumgardner, January N. ;
Shankar, Kartik ;
Hennings, Leah ;
Badger, Thomas M. ;
Ronis, Martin J. J. .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2008, 294 (01) :G27-G38
[3]
Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes [J].
Berson, A ;
De Beco, V ;
Lettéron, P ;
Robin, MA ;
Moreau, C ;
El Kahwaji, J ;
Verthier, N ;
Feldmann, G ;
Fromenty, B ;
Pessayre, D .
GASTROENTEROLOGY, 1998, 114 (04) :764-774
[4]
Immunohistochemical detection of myeloperoxidase and its oxidation products in Kupffer cells of human liver [J].
Brown, KE ;
Brunt, EM ;
Heinecke, JW .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (06) :2081-2088
[5]
Molecular mediators of hepatic steatosis and liver injury [J].
Browning, JD ;
Horton, JD .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (02) :147-152
[6]
Defining high-fat-diet rat models:: metabolic and molecular effects of different fat types [J].
Buettner, R. ;
Parhofer, K. G. ;
Woenckhaus, M. ;
Wrede, C. E. ;
Kunz-Schughart, L. A. ;
Schoelmerich, J. ;
Bollheimer, L. C. .
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2006, 36 (03) :485-501
[7]
Hepatic cytochrome p450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis [J].
Chalasani, N ;
Gorski, JC ;
Asghar, MS ;
Asghar, A ;
Foresman, B ;
Hall, SD ;
Crabb, DW .
HEPATOLOGY, 2003, 37 (03) :544-550
[8]
Hepatic steatosis: Innocent bystander or guilty party? [J].
Day, CP ;
James, OFW .
HEPATOLOGY, 1998, 27 (06) :1463-1466
[9]
Steatohepatitis induced by intragastric overfeeding in mice [J].
Deng, QG ;
She, HY ;
Cheng, JH ;
French, SW ;
Koop, DR ;
Xiong, SG ;
Tsukamoto, H .
HEPATOLOGY, 2005, 42 (04) :905-914
[10]
Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI [10.1172/JCI200523621, 10.1172/JCI23621]